Paper8934049
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.
Hendry JH and 8 others. Clin Oncol (R Coll Radiol), 1996. Cited by 105 papers, by iCite.
Cite this record
ConductScience Library. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Papers, record 8934049. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8934049
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Head and Neck Neoplasms | Major topic |
| Radiotherapy, Computer-Assisted | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| Brachytherapy | |
| Dose-Response Relationship, Radiation | |
| Female | |
| Humans | |
| Models, Theoretical | |
| Radioisotope Teletherapy | |
| Radiotherapy Dosage | |
| Time Factors |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 11527305 | Outcomes of cervix cancer treatments in 1993. | https://conductscience.org/library/papers/11527305 |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42908819 | Calendar-defined missed-workday gaps in radiotherapy: a site- and phase-stratified audit with linkage sensitivity analyses. | Front Oncol | 2026 | https://conductscience.org/library/papers/42908819 | PubMed |
| 41621013 | Managing unplanned radiotherapy interruptions in Italy: results from an AIRO survey. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41621013 | PubMed |
| 40525433 | Oral Metronomic Chemotherapy in Nasopharyngeal Carcinoma with Radiotherapy Interruptions: A Lesson Learned from the Lockdown Due to COVID-19. | Recent Pat Anticancer Drug Discov | 2026 | https://conductscience.org/library/papers/40525433 | PubMed |
| 39468713 | Elevated α/β ratio after hypofractionated radiotherapy correlated with DNA damage repairment in an experimental model of prostate cancer. | J Radiat Res | 2024 | https://conductscience.org/library/papers/39468713 | PubMed |
| 39109283 | Management and outcomes of breast cancer patients with radiotherapy interruption. | Front Oncol | 2024 | https://conductscience.org/library/papers/39109283 | PubMed |
| 37232849 | Investigating Predictive Factors of Dysphagia and Treatment Prolongation in Patients with Oral Cavity or Oropharyngeal Cancer Receiving Radiation Therapy Concurrently with Chemotherapy. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37232849 | PubMed |
| 37091186 | Effect of radiotherapy interruption on nasopharyngeal cancer. | Front Oncol | 2023 | https://conductscience.org/library/papers/37091186 | PubMed |
| 36852328 | Machine Learning-Based Multiomics Prediction Model for Radiation Pneumonitis. | J Oncol | 2023 | https://conductscience.org/library/papers/36852328 | PubMed |
| 35907097 | Towards personalised dosimetry in patients with liver malignancy treated with 90Y-SIRT using in vivo-driven radiobiological parameters. | EJNMMI Phys | 2022 | https://conductscience.org/library/papers/35907097 | PubMed |
| 32307313 | [Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context]. | Cancer Radiother | 2020 | https://conductscience.org/library/papers/32307313 | PubMed |
| 32095592 | Awareness and surveillance of radiation treatment schedules reduces head and neck overall treatment time. | Tech Innov Patient Support Radiat Oncol | 2019 | https://conductscience.org/library/papers/32095592 | PubMed |
| 31574418 | Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC). | Eur J Cancer | 2019 | https://conductscience.org/library/papers/31574418 | PubMed |
| 30858768 | Management of interruptions in radiotherapy treatments: Adaptive implementation in high workload sites. | Rep Pract Oncol Radiother | 2019 | https://conductscience.org/library/papers/30858768 | PubMed |
| 29273054 | Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor. | Radiat Oncol | 2017 | https://conductscience.org/library/papers/29273054 | PubMed |
| 27815711 | The "rocky treatment course": identifying a high-risk subgroup of head and neck cancer patients for supportive interventions. | Support Care Cancer | 2017 | https://conductscience.org/library/papers/27815711 | PubMed |
| 26549990 | Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature. | Rep Pract Oncol Radiother | 2015 | https://conductscience.org/library/papers/26549990 | PubMed |
| 25806305 | Radiotherapy for single station N2 NSCLC. | Transl Lung Cancer Res | 2014 | https://conductscience.org/library/papers/25806305 | PubMed |
| 25460164 | A matter of timing: identifying significant multi-dose radiotherapy improvements by numerical simulation and genetic algorithm search. | PLoS One | 2014 | https://conductscience.org/library/papers/25460164 | PubMed |
| 24526276 | Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy. | JAMA Otolaryngol Head Neck Surg | 2014 | https://conductscience.org/library/papers/24526276 | PubMed |
| 23787766 | Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response. | Phys Med Biol | 2013 | https://conductscience.org/library/papers/23787766 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8934049
GET https://conductscience.org/api/papers/v1/8934049/cited_by?page=2